Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis.
No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients.
The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.
A mechanism-based classification of pain in multiple sclerosis.
Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS).
TCR Bias and HLA Cross-Restriction Are Strategies of Human Brain-Infiltrating JC Virus-Specific CD4+ T Cells during Viral Infection.
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis; From the Safety Assessment of Biologic ThERapy (SABER) Study.
Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study.
Early accurate diagnosis crucial in multiple sclerosis.
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.
An anomalous case of acute coronary syndrome: the unexpected autoimmune duo.
Disease mechanisms in MS: RNA profiling uncovers two distinct subsets of patients with multiple sclerosis.
Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis.
Demyelination and other neurological adverse events after anti-TNF therapy.
Application of laser radiation and magnetostimulation in therapy of patients with multiple sclerosis.
Liver X Receptors differentially modulate central myelin gene mRNA levels in a region-, age- and isoform-specific manner.
[The quality of nighttime sleep in patients with multiple sclerosis].
Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models.
Progress of mesenchymal stem cell therapy for neural and retinal diseases.
Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelination.
Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina.
Spinal cord imaging in multiple sclerosis: Filling the gap with the brain.
Dalfampridine: A Medication to Improve Walking in Patients with Multiple Sclerosis (July/August).
Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.

Pages